Monitoring Clinical Trials Based on Predictive Probability of Significance
From MaRDI portal
Publication:3201537
DOI10.2307/2532056zbMATH Open0715.62236OpenAlexW2330789131WikidataQ45034430 ScholiaQ45034430MaRDI QIDQ3201537FDOQ3201537
Patricia A. Pepple, Sung C. Choi
Publication date: 1989
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2532056
Recommendations
- STATISTICAL METHODS FOR MONITORING CLINICAL TRIALS
- Statistical monitoring of clinical trials. A unified approach.
- Efficacy and toxicity monitoring via Bayesian predictive probabilities in phase II clinical trials
- Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials
interim analysisclinical trialpredictive probabilitycomparing the means of two normal populationscurtailed procedure
Cited In (10)
- CONDITIONAL PROBABILITY OF SIGNIFICANCE FOR EARLY STOPPING IN FAVOR OFH0
- Two useful distributions for Bayesian predicitve procedures under normal models
- Index and prevision of satisfaction in exponential models for clinical trials
- Uses, Abuses and Misuses of Significance Tests in the Scientific Community: Won't the Bayesian Choice be Unavoidable?
- Bayesian sequential analysis of clinical trials feedback
- On the curtailment of sampling
- Assessing a vector of clinical observations
- Monitoring Accumulating Data in a Clinical Trial
- Interim analyses and early termination of clinical trials
- Bayesian interim analysis of lifetime data
This page was built for publication: Monitoring Clinical Trials Based on Predictive Probability of Significance
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3201537)